Oruka Therapeutics, Inc. Earnings Per Share (Diluted)
Oruka Therapeutics, Inc. (ORKA) reported Earnings Per Share (Diluted) of -$0.46 per share for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2025-08-11
- Oruka Therapeutics, Inc. earnings per share, diluted for the quarter ending 2025-06-30 was -$0.46.
- Oruka Therapeutics, Inc. earnings per share, diluted for the quarter ending 2025-03-31 was -$0.40.
- Oruka Therapeutics, Inc. earnings per share, diluted for the quarter ending 2024-09-30 was -$1.46.
- Oruka Therapeutics, Inc. earnings per share, diluted for the quarter ending 2024-06-30 was -$6.96.
- Oruka Therapeutics, Inc. earnings per share, diluted for fiscal 2023 was -$0.37.
- Oruka Therapeutics, Inc. earnings per share, diluted for fiscal 2022 was -$0.69.
- Oruka Therapeutics, Inc. earnings per share, diluted for fiscal 2021 was -$1.39.
| Period end | Earnings Per Share, Diluted 2 month | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 5 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 8 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 11 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | -$0.46 10-Q · filed 2025-08-11 | -$0.85 10-Q · filed 2025-08-11 | |||||||
| 2025-03-31 | -$0.40 10-Q · filed 2025-05-14 | ||||||||
| 2024-12-31 | -$3.87 10-K · filed 2025-03-06 | ||||||||
| 2024-09-30 | -$1.46 10-Q · filed 2024-11-13 | -$6.08 10-Q · filed 2024-11-13 | |||||||
| 2024-06-30 | -$6.96 10-Q · filed 2025-08-11 | -$0.18 10-Q · filed 2024-08-01 | -$9.17 10-Q · filed 2025-08-11 | -$0.32 10-Q · filed 2024-08-01 | |||||
| 2024-03-31 | -$2.21 10-Q · filed 2025-05-14 | -$0.14 10-Q · filed 2024-04-25 | |||||||
| 2023-12-31 | -$0.37 10-K · filed 2024-02-01 | ||||||||
| 2023-09-30 | -$0.10 10-Q · filed 2023-10-18 | -$0.29 10-Q · filed 2023-10-18 | |||||||
| 2023-06-30 | -$0.10 10-Q · filed 2024-08-01 | -$0.20 10-Q · filed 2024-08-01 | |||||||
| 2023-03-31 | -$0.09 10-Q · filed 2024-04-25 | ||||||||
| 2022-12-31 | -$0.69 10-K · filed 2024-02-01 | ||||||||
| 2022-09-30 | -$0.16 10-Q · filed 2023-10-18 | -$0.61 10-Q · filed 2023-10-18 | |||||||
| 2022-06-30 | -$0.22 10-Q · filed 2023-07-21 | -$0.45 10-Q · filed 2023-07-21 | |||||||
| 2022-03-31 | -$0.23 10-Q · filed 2023-04-24 | ||||||||
| 2021-12-31 | -$1.39 10-K · filed 2023-02-24 | ||||||||
| 2021-09-30 | -$0.33 10-Q · filed 2022-10-28 | -$0.99 10-Q · filed 2022-10-28 | |||||||
| 2021-06-30 | -$0.34 10-Q · filed 2022-08-02 | -$0.67 10-Q · filed 2022-08-02 | |||||||
| 2012-06-30 | -$0.09 10-Q · filed 2012-08-13 | -$0.21 10-Q · filed 2012-08-13 | |||||||
| 2011-06-30 | $0.03 10-Q · filed 2012-08-13 | -$0.20 10-Q · filed 2012-08-13 | |||||||
| 2010-06-30 | -$0.26 10-Q · filed 2011-08-15 | -$0.58 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |